Table 3.
Respiratory conditions COVID-19-related.
| Respiratory conditions COVID-related | Papers | N° affected subjects/ Tot |
N° affected subjects_ICU/ Tot_ICU |
N° affected subjects non_ICU/ Tot_non_ICU |
|---|---|---|---|---|
| ARDS | Albu et al. (2021) | 6/30 | 6/16 | 0/14 |
| Negrini et al. (2021) | 9/9 | 5/5 | 4/4 | |
| Mattioli et al. (2022) | 43/215 | 43/52 | 0/163 | |
| Pneumonia | Albu et al. (2021) | 24/30 | 16/16 | 8/14 |
| Bonizzato et al. (2022) | 6/12 | 0/0 | 6/12 | |
| Di Pietro et al. (2021) | 9/12 | 4/7 | 5/6 | |
| Pulmonary embolism | Albu et al. (2021) | 4/30 | 4/16 | 0/14 |
| Mattioli et al. (2022) | 7/215 | 7/52 | 0/163 | |
| Raman et al. (2021) | 7/58 | NA | NA | |
| Cough | Almeria et al. (2020) | 31/35 | NA | NA |
| Mattioli et al. (2021) | 1/120 | 0/0 | 1/120 | |
| Raman et al. (2021) | 35/58 | NA | NA | |
| Breathing difficulties/shortness of breath | Raman et al. (2021) | 51/58 | NA | NA |
| Almeria et al. (2020) | 33/35 | NA | NA | |
| Graham et al. (2021) | 17/50 | 0/0 | 0/0 | |
| COPD | De Lorenzo et al. (2020) | 2/185 | NA | 2/126 |
| Dyspnea | De Lorenzo et al. (2020) | 58/185 | NA | 40/126 |
| Mattioli et al. (2021) | 13/102 | 0/0 | 13/102 | |
| Tachypnoea | De Lorenzo et al. (2020) | 41/185 | NA | 33/126 |
| Asthma | Miskowiak et al. (2021) | 10/29 | 0/0 | 10/29 |
| Hypoxia/hypoxemic respiratory failure | Jaywant et al. (2021) | 50/56 | NA | NA |
ARDS: Acute Respiratory Distress Syndrome; COPD: Chronic Obstructive Pulmonary Disease.